Combined Results from Three Phase II Trials of Neoadjuvant Chemotherapy in Operable Adenocarcinoma of the Oesophagus
- 30 June 2001
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 13 (3) , 164-169
- https://doi.org/10.1053/clon.2001.9246
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Two-field radical lymphadenectomy in the treatment of esophageal carcinoma *Diseases of the Esophagus, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- Current Status of New Drugs and Multidisciplinary Approaches in Patients With Carcinoma of the EsophagusChest, 1998
- A Phase II trial of cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusClinical Oncology, 1998
- A phase II trial of preoperative mitomycin, cisplatin and 5-fluorouracil in adenocarcinoma of the oesophagusClinical Oncology, 1998
- A Comparison of Multimodal Therapy and Surgery for Esophageal AdenocarcinomaNew England Journal of Medicine, 1996
- Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagusCancer Chemotherapy and Pharmacology, 1996
- Radical Lymph Node Dissection for Cancer of the Thoracic EsophagusAnnals of Surgery, 1994
- Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report.Journal of Clinical Oncology, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958